|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-1-19
|
|
pubmed:abstractText |
The pattern of metastasis for Stage IV endometrial carcinoma (EC) is similar to that for ovarian carcinoma (OC), hence the goal of surgical management for both diseases is optimal cytoreduction (CRS) followed by adjuvant chemotherapy. The objective of this study is to evaluate overall survival (OS) and progression-free survival (PFS) in patients with advanced EC compared to a cohort of patients with OC matched for age and residual disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1095-6859
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
337-41
|
|
pubmed:dateRevised |
2009-6-30
|
|
pubmed:meshHeading |
pubmed-meshheading:19041126-Adult,
pubmed-meshheading:19041126-Aged,
pubmed-meshheading:19041126-Aged, 80 and over,
pubmed-meshheading:19041126-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19041126-Case-Control Studies,
pubmed-meshheading:19041126-Chemotherapy, Adjuvant,
pubmed-meshheading:19041126-Cohort Studies,
pubmed-meshheading:19041126-Disease-Free Survival,
pubmed-meshheading:19041126-Endometrial Neoplasms,
pubmed-meshheading:19041126-Female,
pubmed-meshheading:19041126-Humans,
pubmed-meshheading:19041126-Middle Aged,
pubmed-meshheading:19041126-Neoplasm Metastasis,
pubmed-meshheading:19041126-Neoplasm Staging,
pubmed-meshheading:19041126-Organoplatinum Compounds,
pubmed-meshheading:19041126-Ovarian Neoplasms,
pubmed-meshheading:19041126-Radiotherapy, Adjuvant,
pubmed-meshheading:19041126-Survival Rate,
pubmed-meshheading:19041126-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. lisa-landrum@ouhsc.edu
|
|
pubmed:publicationType |
Journal Article
|
